DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency
The mechanisms by which in vivo expression of the Yamanaka transcription factors (OSKM) renders somatic cells permissive for differentiation remain unclear. Here, the authors show that in vivo reprogramming using OSKM generates germ cell tumors and drives acquisition of totipotency-like features in...
Guardado en:
Autores principales: | Jumpei Taguchi, Hirofumi Shibata, Mio Kabata, Masaki Kato, Kei Fukuda, Akito Tanaka, Sho Ohta, Tomoyo Ukai, Kanae Mitsunaga, Yosuke Yamada, So I Nagaoka, Sho Yamazawa, Kotaro Ohnishi, Knut Woltjen, Tetsuo Ushiku, Manabu Ozawa, Mitinori Saitou, Yoichi Shinkai, Takuya Yamamoto, Yasuhiro Yamada |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce67fa07507345ab98bca02b31126aed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of distinct loci for de novo DNA methylation by DNMT3A and DNMT3B during mammalian development
por: Masaki Yagi, et al.
Publicado: (2020) -
In vivo reprogramming drives Kras-induced cancer development
por: Hirofumi Shibata, et al.
Publicado: (2018) -
Totipotency of mouse zygotes extends to single blastomeres of embryos at the four-cell stage
por: Marino Maemura, et al.
Publicado: (2021) -
Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas
por: Shingo Komura, et al.
Publicado: (2019) -
Defining the genomic signature of totipotency and pluripotency during early human development.
por: Amparo Galan, et al.
Publicado: (2013)